These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 34481241)
1. Nanopore detects γ-radiation inhibited HIV-1 protease activity. Li M; Li W; Xiao Y; Liu Q; Liang L; Wang D; Huang W; Wang L Biosens Bioelectron; 2021 Dec; 194():113602. PubMed ID: 34481241 [TBL] [Abstract][Full Text] [Related]
2. Real-time label-free measurement of HIV-1 protease activity by nanopore analysis. Wang L; Han Y; Zhou S; Guan X Biosens Bioelectron; 2014 Dec; 62():158-62. PubMed ID: 24997370 [TBL] [Abstract][Full Text] [Related]
3. Ordered processing of the human immunodeficiency virus type 1 GagPol precursor is influenced by the context of the embedded viral protease. Pettit SC; Clemente JC; Jeung JA; Dunn BM; Kaplan AH J Virol; 2005 Aug; 79(16):10601-7. PubMed ID: 16051852 [TBL] [Abstract][Full Text] [Related]
4. Initial cleavage of the human immunodeficiency virus type 1 GagPol precursor by its activated protease occurs by an intramolecular mechanism. Pettit SC; Everitt LE; Choudhury S; Dunn BM; Kaplan AH J Virol; 2004 Aug; 78(16):8477-85. PubMed ID: 15280456 [TBL] [Abstract][Full Text] [Related]
5. Development of a Bio-Layer Interferometry-Based Protease Assay Using HIV-1 Protease as a Model. Miczi M; Diós Á; Bozóki B; Tőzsér J; Mótyán JA Viruses; 2021 Jun; 13(6):. PubMed ID: 34205716 [TBL] [Abstract][Full Text] [Related]
7. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 protease regulation: the role of the major homology region and adjacent C-terminal capsid sequences. Gatlin J; Arrigo SJ; Schmidt MG J Biomed Sci; 1998; 5(4):305-8. PubMed ID: 9691224 [TBL] [Abstract][Full Text] [Related]
9. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins. Wu X; Liu H; Xiao H; Kappes JC Virology; 1996 May; 219(1):307-13. PubMed ID: 8623547 [TBL] [Abstract][Full Text] [Related]
10. Triggering HIV polyprotein processing by light using rapid photodegradation of a tight-binding protease inhibitor. Schimer J; Pávová M; Anders M; Pachl P; Šácha P; Cígler P; Weber J; Majer P; Řezáčová P; Kräusslich HG; Müller B; Konvalinka J Nat Commun; 2015 Mar; 6():6461. PubMed ID: 25751579 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity. Yu FH; Wang CT Retrovirology; 2018 Apr; 15(1):32. PubMed ID: 29655366 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555 [TBL] [Abstract][Full Text] [Related]
13. A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation. Wondrak EM; Nashed NT; Haber MT; Jerina DM; Louis JM J Biol Chem; 1996 Feb; 271(8):4477-81. PubMed ID: 8626801 [TBL] [Abstract][Full Text] [Related]
14. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles. Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236 [TBL] [Abstract][Full Text] [Related]
15. Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme. Park JH; Sayer JM; Aniana A; Yu X; Weber IT; Harrison RW; Louis JM Biochemistry; 2016 Apr; 55(16):2390-400. PubMed ID: 27039930 [TBL] [Abstract][Full Text] [Related]
16. NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal. Trinité B; Zhang H; Levy DN Retrovirology; 2019 Jun; 16(1):17. PubMed ID: 31242909 [TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus (HIV) type 1 transframe protein can restore activity to a dimerization-deficient HIV protease variant. Dautin N; Karimova G; Ladant D J Virol; 2003 Aug; 77(15):8216-26. PubMed ID: 12857890 [TBL] [Abstract][Full Text] [Related]
19. Exploring the flap dynamics of the South African HIV subtype C protease in presence of FDA-approved inhibitors: MD study. Maphumulo SI; Halder AK; Govender T; Maseko S; Maguire GEM; Honarparvar B; Kruger HG Chem Biol Drug Des; 2018 Nov; 92(5):1899-1913. PubMed ID: 30003668 [TBL] [Abstract][Full Text] [Related]
20. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines. zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]